Document is current

Any future updates will be listed below

Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma

Crossref DOI link: https://doi.org/10.1186/S40880-016-0163-6

Published: 2016-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark